CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

July 9, 2025

Period of Report

July 8, 2025

Accession Number

0002007191-25-000055